Patents by Inventor Dominique Belpomme

Dominique Belpomme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating electrohypersensitivity with a fermented papaya preparation
    Patent number: 10993980
    Abstract: Present disclosure provides a pharmaceutical composition or a preparation composition containing fermented papaya preparation as an active ingredient for treating a patient with electrohypersensitivity or relieving a symptom thought to be a symptom of the electrohypersensitivity, and methods of use thereof.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: May 4, 2021
    Assignee: Osato International Inc.
    Inventors: Yukiyasu Hayashi, Dominique Belpomme
  • Pharmaceutical Composition for Treatment of Electrohypersensitivity
    Publication number: 20200061140
    Abstract: Present disclosure provides a pharmaceutical composition or a preparation composition containing fermented papaya preparation as an active ingredient for treating a patient with electrohypersensitivity or relieving a symptom thought to be a symptom of the electrohypersensitivity, and methods of use thereof.
    Type: Application
    Filed: August 27, 2019
    Publication date: February 27, 2020
    Applicant: Osato International Inc.
    Inventors: Yukiyasu Hayashi, Dominique Belpomme
  • METHYLGLYOXAL AS A MARKER OF CANCER
    Publication number: 20150301056
    Abstract: A reliable, sensitive and easy to handle diagnostic and prognostic test of cancer, includes measuring and analyzing the production of methylglyoxal (MG) from metabolically active cancer cells; in biological samples of extracellular fluids, cells and/or tissues of human or animal subjects. It uses any chemical or immunological in vitro method for MG measurement and it provides a kit for the early detection, screening and diagnosis of cancer; for the staging of cancer, for predicting the survival odds of cancer patients, for monitoring therapeutic response to anticancer programs (including prevention and prophylactic treatments), and for prediction and early detection of cachexia.
    Type: Application
    Filed: October 25, 2013
    Publication date: October 22, 2015
    Applicant: ASSOCIATION POUR LA RECHERCHE THERAPEUTIQUE ANTI-CANCEREUSE
    Inventors: Dominique Belpomme, Philippe Irigaray